Physicians gear up for greater scrutiny under Sunshine Act

Doctors are preparing for greater public scrutiny of the gifts and payments medical device makers and drugmakers give them as companies record almost all transactions with physicians in accordance with the Sunshine Act beginning this month. Greater disclosures are pushing doctors to reconsider their relationships with manufacturers. "The idea is that transparency will encourage doctors to evaluate whether these are appropriate relationships with companies or not," the Pew Charitable Trusts' Dr. Daniel Carlat said.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ